NanoViricides (NYSE-A:NNVC) announced the closing of its previously disclosed registered direct offering, raising about $2 million in gross proceeds before fees and expenses. The clinical-stage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results